BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26903584)

  • 1. Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment.
    Swartz RH; Cayley ML; Lanctôt KL; Murray BJ; Smith EE; Sahlas DJ; Herrmann N; Cohen A; Thorpe KE
    Stroke; 2016 Mar; 47(3):807-13. PubMed ID: 26903584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
    Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
    Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
    Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
    Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery.
    Pendlebury ST; Welch SJ; Cuthbertson FC; Mariz J; Mehta Z; Rothwell PM
    Stroke; 2013 Jan; 44(1):227-9. PubMed ID: 23138443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive impairment 3-6 months after stroke.
    Dong Y; Venketasubramanian N; Chan BP; Sharma VK; Slavin MJ; Collinson SL; Sachdev P; Chan YH; Chen CL
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):580-5. PubMed ID: 22496580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test accuracy of short screening tests for diagnosis of delirium or cognitive impairment in an acute stroke unit setting.
    Lees R; Corbet S; Johnston C; Moffitt E; Shaw G; Quinn TJ
    Stroke; 2013 Nov; 44(11):3078-83. PubMed ID: 23988641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "DOC" screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics.
    Swartz RH; Cayley ML; Lanctôt KL; Murray BJ; Cohen A; Thorpe KE; Sicard MN; Lien K; Sahlas DJ; Herrmann N
    PLoS One; 2017; 12(4):e0174451. PubMed ID: 28376127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montreal Cognitive Assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration.
    Wong A; Nyenhuis D; Black SE; Law LS; Lo ES; Kwan PW; Au L; Chan AY; Wong LK; Nasreddine Z; Mok V
    Stroke; 2015 Apr; 46(4):1059-64. PubMed ID: 25700290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of educational background on Montreal Cognitive Assessment screening for vascular cognitive impairment, no dementia, caused by ischemic stroke.
    Wu Y; Wang M; Ren M; Xu W
    J Clin Neurosci; 2013 Oct; 20(10):1406-10. PubMed ID: 23891119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cog-4 has limited diagnostic test accuracy and validity for cognitive assessment in stroke survivors.
    Lees R; Lua J; Melling E; Miao Y; Tan J; Quinn TJ
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1604-10. PubMed ID: 24674952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Montreal Cognitive Assessment is superior to National Institute of Neurological Disease and Stroke-Canadian Stroke Network 5-minute protocol in predicting vascular cognitive impairment at 1 year.
    Dong Y; Xu J; Chan BP; Seet RC; Venketasubramanian N; Teoh HL; Sharma VK; Chen CL
    BMC Neurol; 2016 Apr; 16():46. PubMed ID: 27067253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular cognitive impairment: most useful subtests of the Montreal Cognitive Assessment in minor stroke and transient ischemic attack.
    Bocti C; Legault V; Leblanc N; Berger L; Nasreddine Z; Beaulieu-Boire I; Yaneva K; Boulanger JM
    Dement Geriatr Cogn Disord; 2013; 36(3-4):154-62. PubMed ID: 23900081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
    Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
    BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between 2 Measures of Cognitive Instrumental Activities of Daily Living and Their Relation to the Montreal Cognitive Assessment in Persons With Stroke.
    Toglia J; Askin G; Gerber LM; Taub MC; Mastrogiovanni AR; O'Dell MW
    Arch Phys Med Rehabil; 2017 Nov; 98(11):2280-2287. PubMed ID: 28478128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cognitive impairment in a stroke prevention clinic using the MoCA.
    Mai LM; Oczkowski W; Mackenzie G; Shuster A; Wasielesky L; Franchetto A; Patlas M; Sahlas DJ
    Can J Neurol Sci; 2013 Mar; 40(2):192-7. PubMed ID: 23419567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Montreal Cognitive Assessment (MoCA) is superior to the Mini Mental State Examination (MMSE) in detection of Korsakoff's syndrome.
    Oudman E; Postma A; Van der Stigchel S; Appelhof B; Wijnia JW; Nijboer TC
    Clin Neuropsychol; 2014; 28(7):1123-32. PubMed ID: 25249353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of three cognitive screening tools in a sample of older New Zealanders.
    Cheung G; Clugston A; Croucher M; Malone D; Mau E; Sims A; Gee S
    Int Psychogeriatr; 2015 Jun; 27(6):981-9. PubMed ID: 25603424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cognitive impairment with the Montreal Cognitive Assessment in Spanish patients with minor stroke or transient ischaemic attack.
    Ramírez-Moreno JM; Bartolomé Alberca S; Muñoz Vega P; Guerrero Barona EJ
    Neurologia (Engl Ed); 2022; 37(1):38-44. PubMed ID: 35074187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.
    Brown DS; Bernstein IH; McClintock SM; Munro Cullum C; Dewey RB; Husain M; Lacritz LH
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):264-72. PubMed ID: 26177715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and facilitating further assessment for cognitive impairment after stroke: application of a shortened Montreal Cognitive Assessment (miniMoCA).
    Campbell N; Rice D; Friedman L; Speechley M; Teasell RW
    Disabil Rehabil; 2016; 38(6):601-4. PubMed ID: 26119578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.